This opinion piece first appeared in Crikey on 26 October2011.
US proposals give Big Pharma more power over patents, prices Dr Deborah Gleeson, a Research Fellow in the School of Public Health and Human Biosciences at La Trobe University, writes:
Leaked documents from the Trans Pacific Partnership (TPP) Agreement negotiations currently under way in Peru show the US is seeking to use the agreement to increase the monopoly rights of pharmaceutical companies and undermine the effectiveness of pharmaceutical reimbursement programs such as Australia’s Pharmaceutical Benefits Scheme.
The TPP is a proposed regional trade agreement involving Australia, Brunei, Chile, Malaysia, New Zealand, Peru, Singapore, the US and Vietnam.
The texts, leaked over the weekend, include an annexe on “transparency and procedural fairness for healthcare technologies” and extra provisions for an intellectual property rights chapter that was leaked in February this year.
The annexe includes clauses that would undermine the…
View original post 447 more words